SearchResearch
Beta
Hello! Describe your research question and I'll help you find matching datasets across 2,944 studies from AnVIL, BDC, CRDC, and KFDRC.

Epigenetic Moderators of Naltrexone Efficacy for Alcohol Use Disorder

Request Access

Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status

Joseph P. Schacht, P. Randall, P. Latham, et al. (2017). Neuropsychopharmacology. Cited 78 times. https://doi.org/10.1038/npp.2017.74

Nicotine‐Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence

R. Anton, P. Latham, K. Voronin, et al. (2018). Alcoholism: Clinical and Experimental Research. Cited 23 times. https://doi.org/10.1111/acer.13601

Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.

R. Anton, K. Voronin, S. Book, et al. (2020). Alcoholism, clinical and experimental research. Cited 10 times. https://doi.org/10.1111/acer.14431

Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: A randomized trial

Joseph P. Schacht, Michaela Hoffman, Brian H. Chen, et al. (2021). The pharmacogenomics journal. Cited 6 times. https://doi.org/10.1038/s41397-021-00250-8